IGFBP3 | insulin like growth factor binding protein 3 | 93 | 5.56E−04 | 0.473 | 0.454 | 0.155 |
TNFSF11 | tumor necrosis factor superfamily member 11 | 110 | 7.21E−04 | 0.482 | 0.474 | 0.153 |
DDIT3 | DNA damage inducible transcript 3 | 72 | 4.52E−04 | 0.479 | 0.500 | 0.160 |
VTN | Vitronectin | 57 | 4.90E−04 | 0.458 | 0.503 | 0.162 |
MET | MET proto-oncogene, receptor tyrosine kinase | 79 | 3.31E−03 | 0.478 | 0.537 | 0.163 |
MYD88 | myeloid differentiation primary response 88 | 102 | 1.22E−03 | 0.483 | 0.528 | 0.147 |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 84 | 5.64E−04 | 0.482 | 0.443 | 0.150 |
PLAU | plasminogen activator, urokinase | 76 | 7.48E−04 | 0.475 | 0.477 | 0.160 |
AHR | aryl hydrocarbon receptor | 80 | 9.65E−04 | 0.476 | 0.429 | 0.154 |
TNFRSF1A | TNF receptor superfamily member 1A | 111 | 1.25E−03 | 0.488 | 0.496 | 0.148 |
BIRC3 | baculoviral IAP repeat containing 3 | 64 | 2.09E−03 | 0.458 | 0.511 | 0.159 |
BIRC2 | baculoviral IAP repeat containing 2 | 65 | 7.52E−04 | 0.462 | 0.446 | 0.147 |
XBP1 | X-box binding protein 1 | 68 | 1.42E−03 | 0.472 | 0.475 | 0.158 |
ERBB3 | erb-b2 receptor tyrosine kinase 3 | 58 | 4.37E−04 | 0.466 | 0.604 | 0.182 |
BIRC5 | baculoviral IAP repeat containing 5 | 49 | 5.75E−04 | 0.445 | 0.514 | 0.154 |
CTSB | cathepsin B | 69 | 5.43E−04 | 0.466 | 0.503 | 0.166 |
EPHA2 | EPH receptor A2 | 47 | 4.29E−04 | 0.460 | 0.537 | 0.173 |
MAP3K5 | mitogen-activated protein kinase kinasekinase 5 | 70 | 4.76E−04 | 0.473 | 0.492 | 0.158 |
ATF6 | activating transcription factor 6 | 51 | 4.21E−04 | 0.461 | 0.511 | 0.165 |
MAPK9 | mitogen-activated protein kinase 9 | 90 | 6.02E−04 | 0.484 | 0.498 | 0.159 |
TNFAIP3 | TNF alpha induced protein 3 | 57 | 1.35E−03 | 0.446 | 0.486 | 0.146 |
TGFBR2 | transforming growth factor beta receptor 2 | 52 | 4.78E−04 | 0.466 | 0.470 | 0.156 |